couter

ADVTAdvantis Corp.

Health CarePharmaceuticals
Nov 20, 2026 — OTC Tier Compliance & Restructuring Deadline
Chart by TradingView

The schedule

  • Fri20Nov

    Anticipated board action deadline to authorize a reverse stock split or severe debt restructuring to maintain OTC quote eligibility.

  • Tue15Dec
  • Tue16Mar
  • Thu25Mar

    Fiscal year-end update and 10-K equivalent filing, expected to include a severe 'going concern' warning unless external capital is miraculously secured.

  • Tue15Jun
  • Tue14Sep

Past

  • Tue15Sep

    Actual outcome: Bear · $0.00 at outcome

    Price reached or fell below bear floor ($0.00) at outcome date.

    Advantis Corp's upcoming quarterly financial report, requiring management to demonstrate any operational viability given effectively zero recent revenue and a massive debt overhang.